The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hold for the BIG BOOM :)
TILS StemPrintER possible RTO candidate ... Thoughts?
We'll see.
I am in and ready!!!
Looks like Richard Griffiths is topping up!
Thanks Sandhopper - a good point
RNS Out
If the share price goes down it's a good opportunity to top up. Manage your average Share Price. Less panic, more strategy!
See RNS
It's a Sonic 'Hold' from me!
NT Only - anyone else?
Fri, 5th Jun 2020 09:15
RNS Number : 1051P
Tissue Regenix Group PLC
05 June 2020
Tissue Regenix Group plc
Director subscriptions/PDMR dealing
Leeds, 5 June 2020 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix", the "Company" or the "Group"), the regenerative medical devices company, announces that following today's release of its annual results, certain members of the Board have conditionally subscribed for a total of £620,000 (the "Subscription"). The Subscription was highlighted in the Company's recent equity fundraising, further details of which were first announced on 21 May 2020 (the "Fundraise").
The Subscription will result in the issue and allotment of a total of 248,000,000 new ordinary shares in the Company and is being carried out at the same issue price of 0.25p and on identical terms as those of the Fundraise.
Director subscriptions
The following Directors have conditionally subscribed for shares in the Company in the amounts set out in the table below:
Director
Current Holding
% of Existing Ordinary Shares
Subscription
Holding post Fundraise
% of Enlarged Share Capital
Jonathan Martin Glenn (Interim Chair)
600,000
0.05%
40,000,000
40,600,000
0.58%
Randeep Singh Grewal (NED)
0
0%
90,000,000
90,000,000
1.28%
Alan Jonathan Richard Miller (NED)
22,886,988
1.95%
94,000,000
116,886,988
1.67%
Gareth Hywel Jones (Interim CEO)
0
0%
24,000,000
24,000,000
0.34%
Total
23,486,988
2%
248,000,000
271,486,988
3.87%
The participation by Jonathan Glenn, Randeep Grewal, Alan Miller and Gareth Jones in the Fundraising constitutes a related party transaction for the purposes of the AIM Rules. The Independent Director, being Shervanthi Homer-Vanniasinkam, having consulted with the Company's nominated adviser, Stifel, consider that the terms of the related party transaction are fair and reasonable insofar as shareholders are concerned.
General meeting and importance of the vote
The Subscription and wider Fundraise is conditional on, amongst other things, the passing of the Placing Resolutions to be proposed at a general meeting to be held at the offices of Squire Patton Boggs (UK) LLP, 6 Wellington Place, Leeds at 12 p.m. on 9 June 2020 (the "General Meeting").